Tofacitinib en el tratamiento de la colitis ulcerosa moderada a grave en Colombia: experiencia en mundo real

Parra-Izquierdo, Viviana; Frías-Ordoñez, Juan Sebastián; Márquez, Juan Ricardo; Juliao-Baños, Fabián; Galindo, Pablo; Cuadros, Carlos; Rojas, Carlos; Rojas, Nelson; Ardila, Oscar; Tovar-Fierro, German.
Gastroenterol. hepatol. (Ed. impr.) ; 46(7): 512-521, Ago-Sep. 2023. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-222850

Documentos relacionados

  1. Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombia: Real world experience.
  2. [Current position on Vedolizumab for ulcerative colitis and Crohn's disease].
  3. [Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
  4. [Ulcerative colitis].
  5. [Living guideline on ulcerative colitis].
  6. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease.
  7. [Management of ulcerative colitis].
  8. [Ulcerative colitis].
  9. [Topical therapy of ulcerative colitis].
  10. What's new in IBD therapy: An "omics network" approach.